iCoreConnect Announces Release Of New Patient Import Tool For iCoreVerify And iCoreVerify+
Portfolio Pulse from Benzinga Newsdesk
iCoreConnect, Inc. (NASDAQ:ICCT) has announced the release of a new patient import tool for iCoreVerify, its automated insurance verification software solution. The new module expands the software's connectivity and integration capabilities, enabling compatibility with all systems and broadening the potential customer base. The tool features an Adaptive Import Mechanism that streamlines workflows and increases efficiencies.
November 07, 2023 | 1:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The release of iCoreConnect's new patient import tool for iCoreVerify could potentially expand its customer base and increase its market reach. This could have a positive impact on the company's revenues and profitability.
The new patient import tool for iCoreVerify expands the software's compatibility with all systems, which could attract more customers. This could lead to increased usage of the software, potentially boosting iCoreConnect's revenues and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100